(Q44822458)

6 December 2017

title

Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). (English)

1 reference

6 December 2017

1 reference

1 reference

P Coursaget

1

1 reference

6 December 2017

B Yvonnet

2

1 reference

6 December 2017

J Chotard

3

1 reference

6 December 2017

M Sarr

4

1 reference

6 December 2017

P Vincelot

5

1 reference

6 December 2017

R N'doye

6

1 reference

6 December 2017

I Diop-Mar

7

1 reference

6 December 2017

J P Chiron

8

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 November 1986

1 reference

6 December 2017

1 reference

6 December 2017

volume

2

1 reference

6 December 2017

issue

8516

1 reference

6 December 2017

page(s)

1143-1145

1 reference

Lack of perinatal transmission of hepatitis B virus infection in Senegal, West Africa

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Hepatitis B virus infection in two Gambian villages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Serological markers of hepatitis B virus and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Immunisation against hepatitis B in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Hepatitis B vaccination: how long does protection last?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Hepatitis B virus contains pre-S gene-encoded domains

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990543-X

7 January 2021

10.1016/S0140-6736(86)90543-X

Identifiers

DOI

1 reference

6 December 2017

1 reference